Project Grant R21AG091727
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a $480,710 Project Grant effective September 5, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). The award supports scientific investigation into a novel vascular signaling pathway that regulates neuronal survival in neurodegenerative diseases, specifically Alzheimer's disease and related dementias (ADRD), amyotrophic lateral sclerosis (ALS), and...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a $622,086 project grant on May 15, 2025, under the Aging Research program (CFDA 93.866) to conduct research investigating microglial NOD2/RIPK2 (nucleotide-binding oligomerization domain-containing protein 2/receptor-interacting serine/threonine-protein kinase 2) signaling in Alzheimer's disease (AD) pathophysiology. The research project, with an anticipated completion date of February...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University $1,083,046 through the Aging Research program (CFDA 93.866) to develop novel adeno-associated virus (AAV) vectors selectively targeting oligodendrocyte precursor cells (OPCs) and to conduct research on their role in Alzheimer's disease pathology. The two-phase project, initiated August 1, 2025 and concluding July 31, 2027, will generate OPC-selective AAV vectors as tools for in vivo...
- Federal Project Grant Award Summary The Johns Hopkins University received a $1.6 million project grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective June 1, 2025 through February 28, 2030. The award supports research investigating the dysfunction of brain microvascular and lymphatic vessels in obesity-linked cognitive impairment. The research aims to develop non-invasive biomarkers for early diagnosis and treatment evaluation of cognitive...
- Federal Project Grant Award Summary The National Institute on Aging awarded a $1.37M Project Grant to Washington University (Office of Sponsored Research Services) under the Aging Research program (CFDA 93.866) effective January 1, 2026, through December 31, 2030. The award funds development of an innovative biocompatible fiber implant designed to enable long-term, deep-brain imaging and manipulation in mouse models of Alzheimer's disease. The implant integrates photoacoustic microscopy (PAM)...
- Federal Grant Award Summary Award Overview: The National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), awarded J. David Gladstone Institutes a Project Grant of $817,357 (awarded June 15, 2025; completion date March 31, 2030) to advance machine learning approaches for behavioral analysis in Alzheimer's disease research. The grant funds development and validation of the Variational Animal Motion Embedding (VAME) platform, an advanced machine learning system designed...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Johns Hopkins University a $682,299 Project Grant effective August 1, 2025 through July 31, 2029 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports development of an ultrafast optical brain imaging technology that combines advanced optics with computational reconstruction algorithms to enhance in vivo...
- Federal Grant Award Summary The University of South Florida received a $1,696,572 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 22, 2025, through May 31, 2030. This award supports transcriptome-wide mapping of the brain M6A (N6-methyladenosine) methylome in Alzheimer's disease. The research will generate three primary deliverables: (1) the first high-resolution reference map of M6A methylation sites across the...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a Project Grant totaling $1,308,967 (awarded May 15, 2025, with completion targeted for January 31, 2030) under the Aging Research program (CFDA 93.866) to develop and apply advanced statistical methods for improving scientific inferences in Alzheimer's Disease (AD) research. The project addresses critical methodological gaps in cross-sectional and longitudinal study designs by creating...
- Federal Grant Award Summary J. David Gladstone Institutes received a $1.46 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) to conduct research on inhibitory neuron dysfunction in Alzheimer's disease models. The award, effective August 1, 2025 through July 31, 2027, supports the development and implementation of innovative methodologies to monitor and manipulate parvalbumin (PVALB) and somatostatin (SST) inhibitory interneuron...
The National Institute on Aging (NIA) awarded The Johns Hopkins University a Project Grant of $618,410 under the Aging Research program (CFDA 93.866) for the period February 1, 2026 through January 31, 2029. The award funds the development of a deep learning-based miniature microscope designed to advance early detection and understanding of Alzheimer's disease (AD) pathology in preclinical models. The research addresses critical limitations in existing imaging technologies by creating an innovative tool capable of imaging the neurovascular unit (NVU)—the integrated system of neurons, blood vessels, and supporting cells—at the spatial and temporal scales necessary to capture AD-related changes including altered functional connectivity, neural hyperactivity, blood flow decline, and endothelial dysfunction. The microscope will enable extended, continuous imaging sessions in awake, freely-behaving animal models while accounting for sleep-wake cycle disruptions and circadian rhythm changes associated with AD onset, substantially improving upon current imaging methods that typically capture data only once every one to two months. The deliverable represents a technological advancement in neuroimaging instrumentation that will generate large-scale, temporally-resolved datasets capturing the early pathogenic cascades of AD in the NVU. By overcoming current hardware design limitations inherent to bulky systems such as positron emission tomography (PET), magnetic resonance (MR), and single-photon emission computed tomography (SPECT), this miniature microscope will provide researchers with enhanced capability to identify presymptomatic AD biomarkers and understand disease mechanisms that precede cognitive decline, thereby supporting the NIA's mission to prevent and treat Alzheimer's disease and its related dementias.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $618.4k | 1/30/26 |